Amisulpride and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amisulpride (amisulpride) and Bumetanide (bumetanide). Common drug interactions include cardiomegaly among females and arteriosclerosis coronary artery among males.

The phase IV clinical study analyzes what interactions people have when they take Amisulpride and Bumetanide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

On Jul, 26, 2026

12 people who take Amisulpride and Bumetanide together, and have interactions are studied.

Amisulpride and Bumetanide drug interactions.

What are the common drug interactions of Amisulpride and Bumetanide, by gender? *:

female:

Cardiomegaly (increased size of heart than normal)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Circulatory collapse
Constipation
Coronary ostial stenosis (narrowing of the mouths of the coronary arteries)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dyspnoea (difficult or laboured respiration)
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Obesity (having too much body fat)

male:

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Fall
Left ventricular failure (left ventricle fails to contract forcefully)

What are the common drug interactions of Amisulpride and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Haemoglobin decreased
Neutropenia (an abnormally low number of neutrophils)

60+:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Circulatory collapse
Constipation
Coronary ostial stenosis (narrowing of the mouths of the coronary arteries)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dyspnoea (difficult or laboured respiration)
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 50.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 41.67%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 25.00%
Psychotic Disorder: 3 people, 25.00%
Agitation (state of anxiety or nervous excitement): 3 people, 25.00%
High Blood Cholesterol: 1 person, 8.33%
Hepatitis (inflammation of the liver): 1 person, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Cardiac Failure Congestive: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously